drugset / Trial / NCT00282698

Outcomes With Tight Control of Hyperglycemia in Cardiac Surgery Patients

NCT00282698

Phase 3 Completed 400 enrolled Mayo Clinic Novo Nordisk A/S · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

Patients with or without diabetes may have high blood sugar levels due to stress response of the body during heart surgery. This study is being done to determine if maintaining normal blood sugar levels during open-heart surgery by using intravenous insulin results in a lesser incidence of death, wound infections in the chest, disturbances of heart rhythm, kidney failure, stroke and prolonged time on the breathing machine (artificial ventilation) within 30 days after surgery.

Timeline

Start
2004-07
Primary completion
2005-05
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic Intravenous

Indications